Abstract
The purpose of the inflammatory process is to combat infection by pathogenic microorganisms. The primary effectors of this response are leukocytes including neutrophils, monocytes, and macrophages. Of necessity, these cells have evolved many properties that facilitate their effective function in inflammation including the ability to move to the site of inflammation (Chemotaxis) and to ingest and kill pathogens by release of toxic products including proteolytic enzymes, reactive oxygen intermediates (ROI), and cationic proteins. Leukocytes have also evolved the ability to respond to signals released in an inflammatory milieu such as bacterial products (formyl peptides and lipopolysaccharide), components of the complement and clotting cascades, and soluble factors such as cytokines released by other inflammatory cells. The processes whereby soluble factors activate leukocyte effector functions (Chemotaxis, proteolytic enzyme secretion, and the oxidative burst) involve complex and interconnected transmembrane signaling pathways. Many of the components of these pathways have been elucidated including the molecular characterization of membrane receptors, GTP-binding proteins, phospholipases, protein kinases, and phosphatases (reviewed in Refs. 1 and 2). Recent studies have provided evidence that free radicals including reactive oxygen intermediates, traditionally viewed as potent microbicidal agents,3 may function in the regulation of these signaling pathways. Reactive oxygen intermediates fulfill important prerequisites for intracellular messenger molecules: they are small, diffusible, and ubiquitous molecules that can be synthesized as well as destroyed rapidly (reviewed in Ref. 4). However, because of their toxicity, there might be only a narrow concentration range in which they can function exclusively as second messengers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Sha’afi, R. I., and T.F.P. Molski. 1988. Activation of the neutrophil. Prog. Allergy 42: 1–64.
Downey, G. P., T. Fukushima, L. Fialkow, and T. K. Waddell. 1995. Intracellular signalling in mechanisms neutrophil priming and activation. Semin. Cell Biol. 6: 345–356.
Cross, A. R., and O.T.G. Jones. 1989. The molecular mechanism of oxygen reduction by the neutrophil oxidase, pp. 97–111. In M. B. Hallet (ed.), The Neutrophil: Cellular Biochemistry and Physiology. CRC Press, Boca Raton, FL.
Schreck, R., and P. A. Baeuerle. 1991. A role for oxygen radicals as second messengers. Trends Cell Biol. 1: 2–3.
Rotrosen, D. 1992. The respiratory burst oxidase, pp. 589–601. In J. I. Gallin, I. M. Goldstein, and R. Snyderman (eds.), Inflammation: Basic Principles and Clinical Correlates, 2nd ed. Raven Press, New York.
Bastian, N. T., and J. B. Hibbs, Jr. 1994. Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr. Opin. Immunol. 6: 131–139.
Morel, F., J. Doussiere, and P. V. Vignais. 1991. The superoxide-generating oxidase of phagocytic cells. Eur. J. Biochem. 201P: 523–546.
Balridge, C. W., and R. W. Gerad. 1933. The extra respiration of phagocytosis. Am. J. Physiol. 103: 235–236.
Halliwell, B., and J.M.C. Gutteridge. 1985. Free radicals as useful species, pp. 246–278. In Free Radicals in Biology and Medicine, 2nd ed. Clarendon Press, Oxford.
Liang, B. and H. R. Petty. 1992. Imaging neutrophil activation: analysis of the translocation and utilization of NAD(P)H-associated autofluorescence during antibody-dependent target oxidation. J. Cell. Physiol. 152: 145–156.
Bovaris, A., and B. Chance. 1973. The mitochondrial generation of hydrogen peroxide. Biochem. J. 134: 707–716.
Turrens, J. F., and A. Bovaris. 1980. Generation of Superoxide anions by the NADPH dehydrogenase of bovine heart mitochondria. Biochem. J. 191: 421–427.
Boveris, A., E. Cadenas, and A.O.M. Stopppani. 1976. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J. 156: 435–444.
Boveris, A., and E. Cadenas. 1975. Mitochondrial production of Superoxide anions and its relationship to antimycin insensitive respiration. FEBS Lett 54: 311–314.
Egan, R. W., J. Paxton, and F. A. Kiehl, Jr. 1976. Mechanisms for the irreversible self deactivation of Prostaglandin synthetase. J. Biol. Chem. 251: 7329–7335.
Kukreja, R. C., H. A. Kontos, M. L. Hess, and E. F. Ellis. 1986. PGH synthase and lipoxygenase generate Superoxide in the presence of NADH or NADPH. Circ. Res. 59: 612–619.
Taylor, A. A., and S. B. Shappell. 1992. Reactive Oxygen species, neutrophil and endothelial adherence molecules, and lipid-derived inflammatory mediators in muocardial ischemia-reperfusion injury, pp. 65–141. In: M. T. Moslen and C. V. Smith (eds.), Free Radical Mechanisms of Tissue Injury. CRC Press, Boca Raton, FL.
Egan, R. W., P. H. Gale, E. M. Baptista, K. L. Kennicott, W.J.A. VandeHeuvel, R. W. Walker, P. E. Fagerness, and F. A. Kuehl, Jr. 1981. Oxidation reactions by Prostaglandin cyclooxygenase-hydroperoxidase. J. Biol. Chem. 246: 7352–7361.
Naccache, P. H., R. I. Sha’afi, and P. Borgeat. 1989. Mobilization, metabolism, and biological effects of eicosanoids in polymorphonuclear leukocytes, pp. 113–139. In M. B. Hallet (ed.), The Neutrophil: Cellular Biochemistry and Physiology. CRC Press, Boca Raton, FL.
Los, M., J. Schenk, K. Hexel, P. A. Baeuerle, W. Dröge, and K. Schulze-Osthoff. 1995. IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J. 14: 3731–3740.
Nebert, D. W., D. R. Nelson, M. J. Coon, R. W. Estabrook, R. Feyereisen, Y. Fujii-Kuriyama, F. J. Gonzalez, F. P. Guengerich, I. C. Gunsalus, E. F. Johnson, J. C. Loper, R. Sato, M. R. Waterman, and D. J. Waxman. 1991. The P450 superfamily: update on new sequences, gene mapping, and recommended momenclature. DNA Cell Biol. 10: 1–14.
Guengerich, P. 1995. Human cytochrome P450 enzymes, pp. 473–535. In R. Ortiz de Montellano (ed.), Cytochrome P-450: Structure, Mechanism, and Biochemistry, 2nd ed. New York: Plenum Press.
Robie-Suh, K., R. Bodinson, and H. V. Gelboin. 1980. Aryl hydrocarbon hydroxylase is inhibited by antibody to rat liver cytochorme P-450. Science 208: 1031–1033.
Kikuta, Y., E. Kusunose, K. Endo, S. Yamamoto, K. Sogawa, Y. Fujii-Kuriyama, and M. Kusunose. 1993. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes: cDNA cloning and expression of leukotriene B4 co-hydroxylase. J. Biol. Chem. 268: 9376–9380.
Shak, S., and I. M. Goldstein. 1985. Leukotriene B4 ω-hydroxylase in human polymorphonuclear leukocytes: partial purification and identification as a cytochrome P-450. J. Clin. Invest. 76: 1218–1228.
McCord, J. M. 1985. Oxygen derived free radicals in post-ischaemic tissue injury. N. Engl. J. Med. 312: 159–163.
Grum, C. M., T. J. Gross, C. H. Mody, and R. G. Sitrin. 1990. Expression of xanthine oxidase activity by murine leukocytes. J. Lab. Clin. Med. 116: 211–218.
Rinaldo, J. E., M. Clark, J. Parinello, and V. L. Shepherd. 1994. Nitric oxide inactivates xanthine dehydrogenase and xanthine oxidase in interferon-γ-stimulated macrophages. Am. J. Respir. Cell. Mol. Biol. 11: 625–640.
Nathan, C., and Q.-W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915–918.
Markert, M., B. Carnal, and J. Mauel. 1994. Nitric oxide production by activated human neutrophils. Biochem. Biophys. Res. Commun. 199: 1245–1249.
McCall, T. B., R.M.J. Palmer, and S. Moncada. 1991. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur. J. Immunol. 21: 2523–2527.
Kubes, P., M. Suzuki, and D. N. Granger. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651–4655.
Gaboury, J., R. C. Woodman, D. N. Granger, P. Reinhardt, and P. Kubes. 1993. Nitric oxide prevents leukocyte adherence: role of Superoxide. Am. J. Physiol. 34: H862–H867.
Kubes, P., I. Kurose, and D. N. Granger. 1994. NO donors prevent integrindependent leukocyte adhesion but not P-selectin-dependent rolling in potischemic venules. Am. J. Physiol. 36: H93l–H937.
Albina, J. E., and J. S. Reichner. 1995. Nitric oxide in inflammation and immunity. New Horizons 3: 46–64.
Lander, H. M., P. K. Sehajpal, and A. Novogrodsyk. 1993. Nitric oxide signaling: a possible role for G proteins. Immunology 151: 7182–7187.
Bolotina, V. M., S. Najibi, J. J. Palacino, P. J. Pagano, and R. A. Cohen. 1994. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth musche. Nature 368: 850–853.
Gopalakrishna, R., Z. H. Chen, and U. Gundimeda. 1993. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. 268: 27180–27185.
Stamler, J. S. 1994. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931–936.
Feigl, E. O. 1988. EDRF-a protrective factor? Nature (London) 331: 490–491.
Rubanyi, G. M., E. H. Ho, E. H. Cantor, W. C. Lumma, and L. H. Botelho. 1991. Cytoprotective function of nitric oxide: inactivation of Superoxide radicals produced by human leukocytes. Biochem. Biophys. Res. Commun. 181: 1392–1397.
Blough, N. V., and O. C. Zafiriou. 1985. Reaction of Superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg. Chem. 24: 3502–3504.
Darley-Usmar, V., H. Wiseman, and B. Halliwell. 1995. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 369: 131–135.
Beckman, J. S., T. W. Bekman, J. Chen, P. M. Marshall, and B. A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc. Natl. Acad. Sci. USA 87: 1620–1624.
Augusto, O., and R. Radi. 1995. Peroxynitrite reactivity: free radical generationk thiol oxidation, and biological significance, pp. 83–116. In L. Packer and E. Cadenas (eds.), Biothiols in Health and Disease. Marcel Dekker, New York.
Haddad, I. Y., G. Pataki, P. Hu, C. Galliani, J. S. Beckman, and S. Matalon. 1994. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94: 2407–2413.
Halliwell, B., and J.M.C. Gutteridge. 1990. Free radicals and metal ions in human disease. Methods Enzymol. 186: 1–85.
Klebanoff, S. J. 1992. Oxygen metabolites from phagocytes, pp. 541–588. In J. I. Gallin, I. M. Goldstein, and R. Snyderman (eds.), Inflammation: Basic Principles and Clinical Correlates, 2nd ed. Raven Press, New York.
Rest, R. F., and J. K. Spitznagel. 1977. Subcellular distribution of Superoxide dismutases in human neutrophils. Influence of myeloperoxidase on the measurement of Superoxide dismutase activity. Biochem. J. 166: 145–153.
Roos, D., R. S. Weening, S. R. Wyss, and H. E. Aebi. 1980. Protection of human neutrophils by endogenous catalase. Studies with cells from catalase-deficient individuals. J. Clin. Invest. 65: 1515–1522.
Voetman, A. A., and D. Roos. 1980. Endogenous catalase protects human blood phagocytes against oxidative damage by extracellularly generated hydrogen peroxide. Blood 56: 846–852.
Spielberg, S. P., L. A. Boxer, J. M. Oliver, J. M. Allen, and J. D. Schulman. 1979. Oxidative damage to neutrophils in glutathione synthetase deficiency. Br. J. Haematol. 42: 215–223.
Roos, D., R. S. Weening, A. A. Boetman, M.L.J. Vanschaik, A.A.M. Bot, L. J. Meerhof, and J. A. Loos. 1979. Protection of phagocytic leukocytes by endogenous glutathione. Studies in a family with glutathione reductase deficiency. Blood 53: 851–866.
Gee, J.B.L., C. L. Vassallo, P. Bell, J. Kaskin, R. E. Basford, and J. B. Field. 1970. Catalase dependent peroxidative metabolism in the alveolar macrophage during phagocytosis. J. Clin. Invest. 49: 1280–1287.
Michaelis, L. and L. B. Flexner. 1928. Oxidation-reduction systems of biological significance. I. The reduction potential of cysteine: its measurement and significance. J. Biol. Chem. 79: 689–722.
Guzman-Baron, E. S. 1951. Thiol groups of biological importance. Adv. Enzymol. Relat. Issues 11: 201–266.
Meister, A. and M. E. Anderson. 1983. Glutathione. [Review]. Annu. Rev. Biochem. 52: 711–760.
Cao, D., L. A. Boxer, and H. R. Petty. 1993. Deposition of reactive oxygen metabolites onto and within living tumor cells during neutrophil-mediated antibody-dependent cellular cytotoxicity. J. Cell. Physiol. 156: 428–436.
Maher, R. J., Cao D., L. A. Boxer, and H. R. Petty. 1993. Simultaneous calciumdependent delivery of neutrophil lactoferrin and reactive oxygen metabolites to erythrocyte targets: evidence supporting granule-dependent triggering of superoxide deposition. J. Cell. Physiol. 156: 226–234.
Storz, G., L. A. Tartaglia, and B. N. Ames. 1990. Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation. Science 248: 189–194.
Hentze, M. W., T. A. Rouault, J. B. Harford, and R. D. Klausner. 1989. Oxidationreduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 244: 358–359.
Ruppersberg, J. P., M. Stocker, O. Pongs, S. H. Heinemann, R. Frank, and M. Koenen. 1991. Regulation of fast inactivation of cloned mammalian Ik(A) channels by cysteine oxidation. Nature 352: 711–714.
Deiss, L. P., and A. Kimchi. 1991. A genetic toll used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 252: 117–120.
Grippo, J. F., A. Holmgren, and W. B. Pratt. 1985. Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. J. Biol. Chem. 260: 93–97.
Ziegler, D. M. 1985. Role of reversible oxidation-reduction of enzyme thiolsdisulfides in metabolic regulation. Annu. Rev. Biochem. 54: 305–329.
Gilbert, H. F. 1984. Redox control of enzyme activities by thiol/disulfide exchange. Methods Enzymol. 107: 330–351.
Huang, C.-K., G. R. Laramee, and J. E. Casnellie. 1988. Chemotactic factor induced tyrosine phosphorylation of membrane associated proteins in rabbit peritoneal neutrophils. Biochem. Biophys. Res. Commun. 151: 794–801.
Berkow, R. L. and R. W. Dodson. 1990. Tyrosine-specific protein phosphorylation during activation of human neutrophils. Blood 75: 2445–2452.
Akimaru, K., T. Utsumi, E. F. Sato, J. Klostergaard, M. Inoue, and K. Utsumi. 1992. Role of tyrosyl phosphorylation in neutrophil priming by tumor necrosis factor-α and granulocyte colony stimulating factor. Arch. Biochem. Biophys. 298: 703–709.
Gomez-Cambronero, J., M. Yamazaki, F. Metwally, T.F.P. Molsky, V. A. Bonak, C.-K. Huang, E. L. Becker, and R. I. Sha’afi. 1989. Granulocyte-macrophage colony-stimulating factor and human neutrophils: role of guanine nucleotide regulatory proteins. Proc. Natl. Acad. Sci. USA 86: 3569–3573.
McColl, S.R., J.F. DiPersio, A.C. Caon, P. Ho, and P. H. Naccache. 1991. Involvement of tyrosine kinases in the activation of human peripheral blood neutrophils by granulocyte-macrophage colony-stimulating factor. Blood 7: 1842–1852.
Gomez-Cambronero, J., E. Wang, G. Johnson, C. K. Huang, and R. I. Sha’afi. 1991. Platelet activating factor induces tyrosine phosphorylation in human neutrophils. J. Biol. Chem. 266: 6240–6245.
Grinstein, S., W. Furuya, D. J. Lu, and G. B. Mills. 1990. Vanadate stimulates oxygen consumption and tyrosine phosphorylation in electropermeabilized human neutrophils. J. Biol Chem. 265: 318–327.
Grinstein, S., and W. Furuya. 1991. Tyrosine phosphorylation and oxygen comsumption induced by G proteins in neutrophils. Am. J. Physiol. (Cell Physiol) 260: C1019–C1027.
Gomez-Cambronero, J., C.-K. Huang, V. A. Bonak, E. Wang, J. E. Casnellie, T. Shiraishi, and R. I. Sha’afi. 1989. Tyrosine phosphorylation in human neutrophils. Biochem. Biophys. Res. Commun. 162: 1478–1485.
Naccache, P. H., C. Gilbert, A. C. Caon, M. Gaudry, C.-K. Huang, V. A. Bonak, K. Umezawa, and S. R. McColl. 1990. Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase. Blood 76:10: 2098–2104.
Gaudry, M., A. C. Caon, C. Gilbert, S. Lille, and P. H. Naccache. 1992. Evidence for the involvement of tyrosine kinases in the locomotory responses of human neutrophils. J. Leukocyte Biol. 51: 103–108.
Laudanna, C., F. Rossi, and G. Berton. 1993. Effect of inhibitors of distinct signalling pathways on neutrophil O2 generation in response to tumor necrosis factor-α, and antibodies against CD18 and CD11a: evidence for a common and unique pattern of sensitivity to wortmannin and protein tyrosine kinase inhibitors. Biochem. Biophys. Res. Commun. 3: 935–940.
Melamed, I., G. P. Downey, and C. M. Roifman. 1991. Tyrosine phosphorylation is essential for microfilament assembly in B lymphocytes. Biochem Biophys. Res. Commun. 3: 1424–1429.
McGregor, P. E., D. K. Agrawal, and J. D. Edwards. 1994. Attenuation of human leukocyte adherence to endothelial cell monolayers by tyrosine kinase inhibitors. Biochem. Biophys. Res. Commun. 198: 359–365.
Greenberg, S., P. Chang, and S. C. Silverstein. 1993. Tyrosine phosphorylation is required for Fc receptor-mediated phagocytosis in mouse macrophages. J. Exp. Med. 177: 529–534.
Fukushima, T., S. Grinstein, T. K. Waddell, G. G. Goss, C. K. Chan, M. Woodside, J. Orlowski, and G. P. Downey. 1996. Molecular and pharmacological characterization of Na+/H+ exchanger in human neutrophils. J. Cell Biol. 132: 1037–1052.
Fukushima, T., D. Rotin, M. Wheeler, and G. P. Downey. Submitted. Cloning and characterization of protein tyrosine phosphatases expressed in human neutrophils.
Waddell, T. K., L. Fialkow, C. K. Chan, T. K. Kishimoto, and G. P. Downey. 1995. Signalling functions of L-selectin: enhancement of tyrosine phosphorylation and activation of MAP kinase. J. Biol Chem. 270: 15403–15411.
Schieven, G. L., J. M. Kirihara, D. L. Burg, R. L. Geahlen, and J. A. Ledbetter. 1993. p72syk tyrosine kinase is activated by oxidizing conditions that induce lymphocyte tyrosine phosphorylation and Ca2+ signals. J. Biol. Chem. 268: 16688–16692.
Fialkow, L., C. K. Chan, S. Grinstein, and G. P. Downey. 1993. Regulation of tyrosine phosphorylation in neutrophils by the NADPH oxidase: role of reactive oxygen intermediates. J. Biol Chem. 268: 17131–17137.
Margoliash, E., A. Novogrodsky, and A. Schejter. 1960. Irreversible reaction of 3-amino-l: 2:4-triazole and related inhibitors with the protein of catalase. Biochem. J. 74: 339–348.
Zor, U., E. Ferber, P. Gergely, K. Szucs, V. Dombradi, and R. Goldman. 1993. Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: potentiation by vanadate. Biochem. J. 295: 879–888.
Trudel, S., M. R. Paquet, and S. Grinstein. 1991. Mechanism of vanadate-induced activation of tyrosine phosphorylation and of the respiratory burst in HL-60 cells: role of reduced oxygen metabolites. Biochem. J. 276: 611–619.
Hayes, G. R., and D. H. Lockwood. 1987. Role of insulin receptor phophorylation in the insulinomimetic effects of hydrogen peroxide. Proc. Natl. Acad. Sci. USA 84: 8115–8119.
Koshio, O., Y. Akanuma, and M. Kasuga. 1988. Hydrogen peroxide stimulates tyrosine phosphorylation of the insulin receptor and its tyrosine kinase activity in intact cells. Biochem. J. 250: 95–101.
Heffetz, D., and Y. Zick. 1989. H2O2 potentiates phosphorylation of novel putative substrates for the insulin receptor kinase in intact fao cells. J. Biol. Chem. 17: 10126–10132.
Heffetz, D., I. Bushkin, R. Dror, and Y. Zick. 1990. The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J. Biol. Chem. 265: 2896–2902.
Cross, A. R., and O.T.G. Jones. 1986. The effect of the inhibitor diphenylene iodonium on the superoxide-generating system in neutrophils: specific labelling of a component Polypeptide of the oxidase. Biochem. J. 237: 111–116.
Stuehr, D. J., O. A. Fasehun, N. S. Kwon, S. S. Gross, J. A. Gonzalez, R. Levi, and C. Nathan. 1991. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 5: 98–103.
Lamas, S., T. Michel, B. M. Brenner, and P.A. Marsden. 1991. Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-α. Am. J. Physiolo. 261 (Cell Physiol 30): C634–C641.
Grinstein, S., and W. Furuya. 1988. Receptor-mediated activation of electropermeabilized neutrophils: evidence for a Ca2+ and protein kinase C-independent signaling pathway. J. Biol. Chem. 263: 1779–1783.
Fialkow, L. 1994. Reactive oxygen intermediates as signaling molecules: implications for acute lung injury. Ph.D. Thesis. Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Seifert, R., R. Burde, and G. Schultz. 1989. Activation of NADPH oxidase by purine and pyrimidine nucleotides involves G proteins and is potentiated by chemotactic peptides. Biochem. J. 259: 813–819.
Grinstein, S., and W. Furuya. 1988. Receptor-mediated activation of electropermeabilized neutrophils: evidence for a Ca2+ and protein kinase C-independent signaling pathway. J. Biol Chem. 263: 1779–1783.
Sklar, L. A., P. A. Hyslop, Z. G. Oades, G. M. Omann, A. J. Jesaitis, R. G. Painter, and C. G. Cochrane. (1985). Signal transduction and ligand-receptor dynamics in the human neutrophil: transient responses and occupacy-response relations at the formyl peptide receptor. J. Biol. Chem. 260: 11461–11467.
Mustelin, T. 1994. Src Family Tyrosine Kinases in Leukocytes, pp. 8–33. R. G. Landes, Austin, TX.
Bauskin, A. R., I. Alkalay, and Y. Ben-Neriah. 1991. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell 66: 1–20.
Asahi, M., T. Taniguchi, E. Hashimoto, T. Inazu, H. Maeda, and H. Yamamura. 1993. Activation of protein-tyrosine kinase p72syk with concanavalin A in polymorphonuclear neutrophils. J. Biol. Chem. 268: 23334–23338.
Ziegler, S. F., J. D. Marth, D. B. Lewis, and R. M. Perlmutter. 1987. Novel proteintyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin. Mol. Cell. Biol. 7: 2276–2285.
Gutkind, J. S., and K. C. Robbins. 1989. Translocation of the FGR protein-tyrosine kinase as a consequence of neutrophil activation. Proc. Natl. Acad. Sci. USA 86: 8783–8787.
Yamada, N., Y. Kawakami, H. Kimura, H. Fukamachi, G. Baier, A. Altman, T. Kato, Y. Inagaki, and T. Kawakami. 1993. Structure and expression of novel protein-tyrosine kinases, EMB and EMT, in hematopoietic cells. Biochem. Biophys. Res. Commun. 192: 231–240.
Brumell, J. H., A. L. Burkhardt, J. B. Bolen, and S. Grinstein. 1996. Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J. Biol. Chem. 271: 1455–1462.
Berton, G., L. Fumagalli, C. Laudanna, and C. Sorio. 1994. β2 integrin-dependent protein tyrosine phosphorylation and activation of the FGR protein tyrosine kinase in human neutrophils. J. Cell Biol. 126: 1111–1121.
Hamada, F., M. Aoki, T. Akiyama, and K. Toyoshima. 1993. Association of Immunoglobulin G Fc receptor II with Src-like protein-tyrosine kinase Fgr in neutrophils. Proc. Natl. Acad. Sci. USA 90: 6305–6309.
Corey, S., A. Eguinoa, K. Puyanatheall, J. B. Bolen, L. Cantley, F. Mollinedo, T. R. Jackson, P. T. Kawkins, and L. R. Stephens. 1993. Granulocyte macrophagecolony stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and src-related tyrosine kinase(s) in human myeloid derived cells. EMBO J 12: 2681–2690.
Gaudry, M., G. F. Barabé, P. E. Poubelle, and P. H. Naccache. 1995. Activation of Lyn is a common element of the stimulation of human neutrophils by soluble and particulate agonists. Blood 86: 3567–3574.
Ptasznik, A., A. Traynor-Kaplan, and G. M. Bokoch. 1995. G protein-coupled chemoattractant receptors regulate Lyn tyrosine kinase Sch adapter protein signaling complexes. J. Biol. Chem. 270: 19969–19973.
Skubitz, K.M., K. D. Campbell, K. Ahmed, and A.P.N. Skubitz. 1995. CD66 family members are associated with tyrosine kinase activity in human neutrophils. J. Immunol. 155: 5382–5390.
Huchcroft, J. E., M. L. Harrison, and R. L. Geahlen. 1992. Association of the 72-kDa protein-tyrosine kinase PTK72 with the B cell antigen receptor. J. Biol. Chem. 267: 8613–8619.
Agarwal, A., P. Salem, and K. C. Robbins. 1993. Involvement of P72syk, a proteintyrosine kinase, in Fcγ receptor signaling. J. Biol. Chem. 268: 15900–15905.
Darby, C., R. L. Geahlen, and A. D. Schreiber. 1994. Stimulation of macrophage FcγRIIIA activated the receptor-associated protein tyrosine kinase syk and induces phosphorylation of multiple proteins including p95vav and p62/GAP-associated protein. J. Immunol. 152: 5429–5437.
Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76: 263–274.
Cooper, J. A., and B. Howeel. 1993. The when and how of src regulation. Cell 73: 1051–1054.
Mustelin, T. 1994. Regulation of src-family PTKs, pp. 34–52. In T. Mustelin (ed.), Src Family Tyrosine Kinases in Leukocytes. R. G. Landes, Austin, TX.
Superti-Fuga, G. 1995. Regualtion of the Src protein kinase. FEBS Lett. 369: 62–66.
Streuli, M., N. X. Krueger, A. Y. Tsai, and H. Saito. 1989. A family of receptorlinked protein tyrosine phosphatases in humans and drosophila. Proc. Natl. Acad. Sci. USA 86: 8698–8702.
Tonks, N. K., C. D. Diltz, and E. H. Fischer. 1988. Characterization of the major protein-tyrosine-phosphatases of human placenta. J. Biol. Chem. 263: 6731–6737.
Stocken, L. A., R. H. S. Thompson. 1946. Arsenic derivatives of thiol proteins. Biochem. J. 40: 529–535.
Garcia-Morales, P., Y. Minami, E. Luong, R. Klausner, and L. E. Samelson. 1992. Tyrosine phosphorylation in T cells is regulated by phopshatase activity: studies with phenylarsine oxide. Proc. Natl. Acad. Sci. USA 87: 9255–9259.
Balloti, R., S. Tartare, A. Chauvel, J.-C. Scimeca, F. Alengrin, C. Filloux, and E. Van Obberghen. 1991. Phenylarsine oxide stimulates a cytosolic tyrosine kinase activity and glucose transport in mouse fibroblasts. Exp. Cell Res. 197: 300–306.
Hecht, D., and Y. Zick. 1992. Selective inhibition of protein tyrosine Phosphatase activities by H2O2 and vanadate in vitro. Biochem. Biophys. Res. Commun. 188: 773–779.
Goldman, R., E. Ferber, and U. Zor. 1992. Reactive oxygen species are second messengers for activation of cellular-phospholipase A2. FEBS Lett. 309: 190–192.
Trudel, S., G. P. Downey, and S. Grinstein. 1990. Activation of permeabilized HL60 cells by vanadate: evidence for divergent signalling pathways. Biochem. J. 269: 127–131.
Pulido, R., V. Alvarez, F. Mollinedo, and F. Sanchez-Madrid. 1992. Biochemical and functional characterization of the leucocyte tyrosine Phosphatase CD45 (CD45RO, 180 kD) from human neutrophils. In vivo upregulation of CD45RO plasma membrane expression on patients undergoing haemodialysis. Clin. Exp. Immunol. 87: 329–335.
Caldwell, C. W., W. P. Patterson, and Y. W. Yesus. 1991. Translocation of CD45RA in neutrophils. J. Leukocyte Biol. 49: 317–318.
Cui, Y., K. Harvey, L. Akard, J. Jansen, C. Hyghes, R. A. Siddiqui, and D. English. 1994. Regulation of neutrophil responses by phosphotyrosine Phosphatase. J. Immunol. 152: 5420–5428.
Mustelin, T., K. M. Coggeshall, and A. Altman. 1989. Rapid activation of the T-cell tyrosine protein kinase pp56lckby the CD45 phosphotyrosine Phosphatase. Proc. Natl. Acad. Sci. USA 86: 6302–6306.
Secrist, J. P., L. A. Burns, L. Karnitz, G. A. Koretzky, and R. T. Abraham. 1993. Stimulatory effects of protein tyrosine Phosphatase inhibitor, pervanadate on T-cell activation events. J. Biol. Chem. 268: 5886–5893.
Fiakow, L., C. K. Chan, and G. P. Downey. Regulation of CD45 in neutrophils by reactive oxygen intermediates. Immunol. 1977.
Fialkow, L., C. K. Chan, D. Rotin, S. Grinstein, and G. P. Downey.1994. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils: role of oxidants. J. Biol. Chem. 269: 31234–31242.
Kansha, M., K. Takeshige, and S. Minakami. 1993. Decrease in the phosphotyrosine Phosphatase activity in the plasma membrane of human neutrophils on stimulation by phorbol 12-myristate 13-acetate. Biochim. Biophys. Acta 1179: 189–196.
Kraft, A. S., and R. L. Berkow. 1987. Tyrosine kinase and phosphotyrosine phosphatase activity in human promyelocytic leukemia cells and human polymorphonuclear leokocytes. Blood 70: 356–362.
Hancock, J. T., and T. G. Jones. 1987. The inhibition by diphenyleneiodonium and its analogues of Superoxide generation by macrophages. Biochem. J. 242: 103–107.
Porter, T. D., and M. J. Coon. 1991. Cytochrome P-450. J. Biol. Chem. 266: 13469–13472.
Emmendörffer, A., J. Roesler, J. Eisner, E. Raeder, M. L. Lohmann-Matthes, and B. Meier. 1993. Production of oxygen radicals by fibroblasts and neutrophils from a patient with X-linked chronic granulomatous disease. Eur. J. Haematol. 51: 223–227.
Tonks, N.K, C. D. Diltz, and E. H. Fischer. 1988. Characterization of the major protein-tyrosine-phosphatases of human placenta. J. Biol. Chem. 263: 6731–6739.
Yamada, A., M. Streuli, H. Saito, D. M. Rothstein, S. F. Scholssman, and C. Morimoto. 1990. Effect of activation of protein kinase C on CD45 isoform expression and CD45 protein tyrosine Phosphatase activity in T cells. Eur. J. Immunol 20: 1655–1660.
Koretzky, G. 1993. A role of the CD45 tyrosine Phosphatase in signal transduction in the immune system. FASEB J. 7: 420–426.
Sun, H., C. H. Charles, L. F. Lau, and N. K. Tonks. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity Phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487–493.
Guy, G. R., J. Cairns, S. B. Ng, and Y. H. Tan. 1993. Inactivation of a redoxsensitive protein Phosphatase during the early events of tumor necrosis factor/ interleukin-1 signal transduction. J. Biol. Chem. 268: 2141–2148.
MacKintosh, R. W., K. N. Dalby, D. G. Campbell, P.T.W. Cohen, P. Cohen, and C. MacKintosh. 1995. The cyanobacterial toxin microcystin binds covalently to cysteine-273 on protein Phosphatase 1. FEBS Lett. 371: 236–240.
Shima, H., H. Tohda, S. Aonuma, M. Nakayasu, A. A. DePaoli-Roach, T. Sumigura, and M. Nagao. 1994. Characterization of the PP2Aα gene mutation in okadaic acid-resistant variants of CHO-K1 cells. Proc. Natl. Acad. Sci. USA 91: 9267–9271.
Brummell, J., C. K. Chan, J. Butler, N. Borregaard, K. Siminovitch, S. Grinstein, and G. P. Downey. Submitted. Regulation of PTP1C during activation of human neutrophils: role of protein kinase C. J. Biol. Chem.
Ahn, N. G., R. Seger, and E. C. Krebs. 1992. The mitogen-activated protein kinase activator. Curr. Opin. Cell. Biol. 4: 992–999.
Crews, C. M., and R. L. Erikson. 1993. Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74: 215–217.
Dent, P., W. Haser, T. A. Haystead, L. A. Vincent, T. M. Roberts, and T. W. Sturgill. 1992. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257: 1404–1407.
Howe, L. R., S. J. Leevers, N. Gomes, S. Nakielny, P. Cohen, and C. J. Marshall. 1992. Activation of the MAP kinase pathway by the protein kinase raf. Cell 71: 335–342.
Kyriakis, J. M., H. App, X.-F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp, and J. Avruch. 1992. Raf-1 activates MAP kinase-kinase. Nature 358: 417–421.
Lange-Carter, C. A., C. M. Pleiman, A. M. Gardner, K. J. Blumer, and G. L. Johnson. 1993. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260: 315–319.
Anderson, N. G., J. L. Maller, N. K. Tonks, and T. W. Sturgill. 1990. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343: 651–652.
Nishizuka, Y. 1988. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661–665.
Kass, G.E.N., S. K. Duddy, and S. Orrenius. 1989. Activation of hepatocyte protein kinase C by redox-cycling quinones. Biochem. J. 260: 499–507.
Gopalakrishna, R., and W. B. Anderson. 1989. Ca2+-and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl Acad. Sci. USA 86: 6758–6762.
Lin, L.-L., M. Wartmann, A. Y. Lin, J. L. Knopf, A. Seth, and R. J. Davis. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269–278.
Durstin, M., S. Durstin, T.F.P. Molski, E. Becker, and R. I. Sha’afi. 1994. Cytolasmic phopholipase A2 translocates to membrane fraction in human neutrophils activated by stimuli that phosphorylate mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 91: 3142–3146.
Schulze-Osthoff, K., M. Los, and P. A. Baeuerle. 1995. Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem. Pharmacol. 50: 735–741.
Salmon, J. E., S. S. Millard, N. L. Brogle, and R. P. Kimberly. 1995. Fcγ receptor 111b enhances FcγIIa function in an oxidant-dependent and allele-sensitive manner. J. Clin. Invest. 95: 2877–2885.
Gresham, H. D., J. A. McGarr, P. G. Shackelford, and E. J. Brown. 1988. Studies on the molecular mechanisms of human Fc receptor-mediated phagocytosis. Amplification of ingestion is dependent on the generation of reactive oxygen metabolites and is deficient in polymorphonuclear from patients with chronic granulomatous disease. J. Clin. Invest. 82: 1192–1201.
Connelly, P. A., C. A. Farrell, J. M. Merenda, M. J. Conklyn, and H. J. Showell. 1991. Tyrosine phosphorylation is an early signaling event common to Fc receptor cross-linking in human neutrophils and rat basophilic leukemia cells (RBL-2H3). Biochem. Biophys. Res. Commun. 1: 192–201.
Scholl P. R., D. Ahern, and R. S. Geha. 1992. Protein tyrosine phosphorylation induced via the IgG receptors FcγRI and FcγRII in the human monocytic cell line THP-1. J. Immunol. 149: 1751–1757.
Greenberg, S., P. Chang, and S. C. Silverstein. 1994. Tyrosine phosphorylation of the γ subunit of Fcγ receptors, p72syk and paxillin during Fc receptor-mediated phagocytosis in macrophages. J. Biol. Chem. 269: 3897–3902.
Zhou, M.-J., D. M. Lublin, D. C. Link, and E. J. Brown. 1995. Distinct tyrosine kinase activation and Triton X-100 insolubility upon FcγRII or FcγRIIIB ligation in human polymorphonuclear leukocytes. J. Biol. Chem. 270: 13553–13560.
Thomas, M. L. 1994. The regulation of B-and T-lymphocyte activation by the transmembrane protein tyrosine Phosphatase CD45. Curr. Opin. Cell Biol. 6: 247–252.
Okumura, M., and M. L. Thomas. 1995. Regulation of immune function by protein tyrosine phosphatases. Curr. Opin. Immunol. 7: 312–319.
Trowbridge, I. S. 1994. CD45: and emerging role as a protein tyrosine Phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12: 85–116.
Staal, F.J.T., Anderson, M. T., Staal, G.E.J., Herzenberg, L. A., Gitler C., and Herzenberg L. N. 1994. Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. Proc. Natl. Acad. Sci. USA. 91: 3619–3622.
Harvath, L., J. A. Balke, N. P. Christiansen, A. A. Russell, and K. M. Skubitz. 1991. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil Chemotaxis. J. Immunol. 146: 949–957.
Hoffmeyer, F., K. Witte, U. Gebhardt, and R. E. Schmidt. 1995. The low affinity FCγRIIa and FCγRIIIb on polymorphonuclear neutrophils are differentially regulated by CD45 Phosphatase. J. Immunol. 155: 4016–4022.
Omann, G. M., J. M. Harter, J. M. Burger, and D. B. Hinshaw. 1994. H2O2-induced increased in cellular F-actin occur without increased in actin nucleation activity. Arch. Biochem. Biophys. 308: 407–412.
Sundaresan, M., Z.-X Yu, V. J. Ferrans, K. Irani, and T. Finkel. 1995. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296–299.
Grinstein, S., W. Furuya, J. R. Butler, and J. Tseng. 1993. Receptor-mediated activation of multiple serine/threonine kinases in human leukocytes. J. Biol. Chem. 268: 20223–20231.
Grinstein, S., and W. Furuya. 1992. Chemoattractant-induced tyrosine phosphorylation and activation of microtubule-associated protein kinase in human neutrophils. J. Biol. Chem. 25: 18122–18125.
Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R. Woodgett. 1991. Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 670–674.
Kramer, R. M. 1993. Structure, function and regulation of mammalian phospholipases A2. Adv. Second Messenger Phosphoprotein Res. 28: 81–89.
Peppelenbosch, M. P., L.G.J. Tertoolen, W. J. Hage, and S. W. De Laat. 1993. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell 74: 565–575.
Haslett, C., S. Savill, M.K.B. Whyte, M. Stern, I. Dransfield, and L. C. Meagher. 1994. Granulocyte apoptosis and the control of inflammation. Phil. Trans. R. Soc. Lond. B. 345: 327–333.
Savill, J. and C. Haslett. 1995. Granulocyte clearance by apoptosis in the resolution of inflammation. Semin. Cell Biol. 6: 385–393.
Buttke, T. M., and P.A. Sandstrom. 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today 15: 7–10.
Lennon, S. V., S. J. Martin, and T. G. Cotter. 1991. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. 24: 203–214.
Greenlund, L. J., T. L. Deckwerth, and E. M. Johnson, Jr. 1995. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14: 303–312.
Yao, X. R., and D. W. Scott. 1994. Antisense oligodeoxynecleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. Proc. Natl. Acad. Sci. USA 90: 7946–7950.
Manabe, A., T. Yi, M. Kumagai, and D. Campana. 1993. Use of strome-supported cultures of leukemic cells to assess antileukemic drugs. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia. Leukemia 7: 1990–1995.
Yousefi, S., D. R. Grenn, K. Blaser, and H.-U. Simon. 1994. Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc. Natl. Acad. Sci. USA 91: 10868–10872.
Schieven, G. L., A. F. Wahl, S. Myrdal, L. Grosmaire, and J. A. Ledbetter. 1995. Lineage-specific induction of B cell apoptosis and altered signal transduction by the phosphotyrosine Phosphatase inhibitor bis (maltolato) oxovanadium (IV). J. Biol. Chem. 270: 20824–20831.
Hanaoka, K., N. Fujita, S. H. Lee, H. Seimiya, M. Naito, and T. Tsuruo. 1995. Involvement of CD45 in adhesion and suppression of apoptosis of mouse malignant T-lymphoma cells. Cancer Res. 55: 2186–2190.
Lin, K.-T., J.-Y. Xue, M. Nonlen, B. Spur, and P. Y.-K. Wong. 1995. Peroxynitriteinduced apoptosis in HL-60 cells. J. Biol. Chem. 270: 16487–16490.
Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10: 2247–2258.
Crawford, D., I. Zbinden, P. Amstad, and P. Cerutti. 1988. Oxidant stress induces the protooncogenes c-fos and c-myc in mouse epidermal cells. Oncogene 3: 27–32.
Nose, K., M. Shibanuma, K. Kikuchi, H. Kageyama, S. Sakiyama, and T. Kuroki. 1991. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur. J. Biochem. 201: 99–106.
Xanthoudakis, S., G. Miao, F. Wang, Y.-C.E. Pan, and T. Curran. 1992. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11: 3323–3335.
Baeuerle, P. A. 1991. The inducible transcrition activator NF-κB: regulation by distinct proteins subunits. Biochim. Biophys. Acta 1072: 63–80.
Ding, A., S. Hwang, H. M. Lander, and Q. W. Xie. 1995. Macrophages derived from C3H/HeJ (Lpsd) mice respond to bacterial lipopolysaccharide by activating NF-kappa B. J. Leukocyte Biol. 57: 174–179.
Xie, Q.-W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-KB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269: 4705–4708.
Müller, J. M., H.W.L. Ziegler-Heitbrock, and P. A. Baeuerle. 1993. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunob. 187: 233–256.
Shakhov, A. N., M. A. Collait, P. Vassalli, A. S. Nedospasov, and C. V. Jongeneei. 1990. KB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in macrophages. J. Exp. Med. 171: 35–47.
Lo, Y. Y. and T. F. Cruz. 1995. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J. Biol. Chem. 270: 11727–11730.
Schulze-Osthoff, K., R. Beyaert, V. Vandevoorde, G. Haegeman, and W. Fiers. 1993. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 8: 3095–3104.
Satriano, J. A., M. Shuldiner, K. Hora, Y. Xing, Z. Shan, and D. Schlondorff. 1993. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1 and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G. J. Clin. Invest. 92: 1564–1571.
Root, R. K., J. Metcalf, N. Oshino, and B. Chance. 1975. H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J. Clin. Invest. 55: 945–955.
Patel, K. C., G. A. Zimmerman, S. M. Precott, R. P. McEver, and T. M. Mclntyre. 1991. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell Biol. 112: 749–759.
Natajaran, V., M. M. Taher, B. Roehm, N. L. Parinandi, H.H.O. Schmid, Z. Kiss, and J.G.N. Garcia. 1993. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J. Biol. Chem. 930–937.
Downey, G. P., and H. O’Brodovich. In press. Mechanisms of lung injury and repair. In L. Tanssig and M. Textbook (eds.), Textbook of Pediatric Respiratory Medicine. Mosby-Yearbook, St. Louis, MO.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Fialkow, L., Downey, G.P. (1997). Reactive Oxygen Intermediates as Signaling Molecules Regulating Leukocyte Activation. In: Forman, H.J., Cadenas, E. (eds) Oxidative Stress and Signal Transduction. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5981-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5981-8_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7741-2
Online ISBN: 978-1-4615-5981-8
eBook Packages: Springer Book Archive